These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 19496782)
1. Randomized trial comparing locoregional resection of primary tumor with no surgery in stage IV breast cancer at the presentation (Protocol MF07-01): a study of Turkish Federation of the National Societies for Breast Diseases. Soran A; Ozbas S; Kelsey SF; Gulluoglu BM Breast J; 2009; 15(4):399-403. PubMed ID: 19496782 [TBL] [Abstract][Full Text] [Related]
2. Matched pair analyses of stage IV breast cancer with or without resection of primary breast site. Cady B; Nathan NR; Michaelson JS; Golshan M; Smith BL Ann Surg Oncol; 2008 Dec; 15(12):3384-95. PubMed ID: 18726129 [TBL] [Abstract][Full Text] [Related]
3. Influence of resection volume on locoregional recurrence of breast cancer after breast-conserving surgery. Boehm DU; Lebrecht A; Maltaris T; Schmidt M; Siggelkow W; Fischer S; Kandelhart E; Koelbl H Anticancer Res; 2008; 28(2B):1207-11. PubMed ID: 18505057 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence. Kuo SH; Huang CS; Kuo WH; Cheng AL; Chang KJ; Chia-Hsien Cheng J Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1456-64. PubMed ID: 18692329 [TBL] [Abstract][Full Text] [Related]
5. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Ruiterkamp J; Ernst MF; van de Poll-Franse LV; Bosscha K; Tjan-Heijnen VC; Voogd AC Eur J Surg Oncol; 2009 Nov; 35(11):1146-51. PubMed ID: 19398188 [TBL] [Abstract][Full Text] [Related]
6. Local control by breast-conserving surgery with nipple resection. Horiguchi J; Koibuchi Y; Iijima K; Yoshida T; Takata D; Rokutanda N; Nagaoka R; Oyama T; Iino Y; Sakurai H; Morishita Y Anticancer Res; 2005; 25(4):2957-9. PubMed ID: 16080550 [TBL] [Abstract][Full Text] [Related]
7. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. Buchholz TA; Lehman CD; Harris JR; Pockaj BA; Khouri N; Hylton NF; Miller MJ; Whelan T; Pierce LJ; Esserman LJ; Newman LA; Smith BL; Bear HD; Mamounas EP J Clin Oncol; 2008 Feb; 26(5):791-7. PubMed ID: 18258988 [TBL] [Abstract][Full Text] [Related]
8. Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival. Bafford AC; Burstein HJ; Barkley CR; Smith BL; Lipsitz S; Iglehart JD; Winer EP; Golshan M Breast Cancer Res Treat; 2009 May; 115(1):7-12. PubMed ID: 18581232 [TBL] [Abstract][Full Text] [Related]
9. [Therapy of the small breast carcinoma--generalized conversion to breast-saving treatment in Germany. 8 years results]. Gatzemeier W; Schumacher M; Schauer A; Sauer R; Rauschecker HF Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1212-4. PubMed ID: 9574381 [TBL] [Abstract][Full Text] [Related]
10. A debate on locoregional treatment of the primary tumor in patients presenting with stage IV breast cancer. Nguyen DH; Truong PT Expert Rev Anticancer Ther; 2011 Dec; 11(12):1913-22. PubMed ID: 22117158 [TBL] [Abstract][Full Text] [Related]
11. The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update). Holmes DR; Baum M; Joseph D Am J Surg; 2007 Oct; 194(4):507-10. PubMed ID: 17826067 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer: a study into the value of a historical group as comparative material for new methods of treatment. Hooning MJ; van Dongen JA; Hart AA; Peterse JL; Bruggink ED; Went G Eur J Surg Oncol; 1992 Feb; 18(1):16-22. PubMed ID: 1737588 [TBL] [Abstract][Full Text] [Related]
13. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage. Monteau A; Sigal-Zafrani B; Kirova YM; Fourchotte V; Bollet MA; Vincent-Salomon A; Asselain B; Salmon RJ; Fourquet A Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1021-8. PubMed ID: 19386441 [TBL] [Abstract][Full Text] [Related]
14. Surgical resection of the primary tumor, chest wall control, and survival in women with metastatic breast cancer. Hazard HW; Gorla SR; Scholtens D; Kiel K; Gradishar WJ; Khan SA Cancer; 2008 Oct; 113(8):2011-9. PubMed ID: 18780312 [TBL] [Abstract][Full Text] [Related]
15. Breast-conservation treatment outcomes: a community hospital's experience. Florentine BD; Kaushal NK; Puig MR; Sarda N; Senofsky G; Cooper BT; Black A; Zimmerman R; Barstis J Breast J; 2009; 15(1):76-84. PubMed ID: 19120383 [TBL] [Abstract][Full Text] [Related]
16. Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy. Kirova YM; Campana F; Savignoni A; Laki F; Muresan M; Dendale R; Bollet MA; Salmon RJ; Fourquet A; Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):76-81. PubMed ID: 19168297 [TBL] [Abstract][Full Text] [Related]
17. Patient and tumor characteristics associated with primary tumor resection in women with Stage IV breast cancer: analysis of 1988-2003 SEER data. Gnerlich J; Dueker JM; Jeffe DB; Deshpande AD; Thompson S; Margenthaler JA Breast J; 2008; 14(6):538-42. PubMed ID: 19000055 [TBL] [Abstract][Full Text] [Related]
18. Prognosis for isolated skin recurrence after breast cancer treated by mastectomy. Jaffre F; Lavoue V; Mesbah H; Rouquette S; Audrain O; Laurent JF; Leveque J Anticancer Res; 2009 May; 29(5):1697-701. PubMed ID: 19443389 [TBL] [Abstract][Full Text] [Related]
19. Locoregional Resection in Stage IV breast cancer: tumor biology, molecular and clinical perspectives. Lang JE; Babiera GV Surg Clin North Am; 2007 Apr; 87(2):527-38, xi-xii. PubMed ID: 17498542 [TBL] [Abstract][Full Text] [Related]
20. Locoregional therapy of breast cancer: maximizing control, minimizing morbidity. Sabel MS Expert Rev Anticancer Ther; 2006 Sep; 6(9):1281-99. PubMed ID: 17020461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]